Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 5% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
2
0% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Commercial Officer | Albireo Pharma Inc | March 25, 2019 - |
| Independent Director | Zynerba Pharmaceuticals Inc | Feb. 19, 2019 - |
Search